20 ML immune globulin subcutaneous (human) - klhw 200 MG/ML Injection [Xembify]
RxNorm concept 2196491, branded drug (sbd). Prescribable name: Xembify 20 % (4 GM in 20 ML) Injection.
- RxCUI
- 2196491
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2196491 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
20 ML Xembify 200 MG/ML Injection; Xembify 20 % (4 GM per 20 ML) Injection
Related concepts
- immune globulin subcutaneous (human) - klhw 200 MG/ML (SCDC, consists of)
- immune globulin subcutaneous (human) - klhw 200 MG/ML [Xembify] (SBDC, consists of)
- Injection (DF, has dose form)
- Xembify (BN, has ingredient)
- 20 ML immune globulin subcutaneous (human) - klhw 200 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2196491 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2196491 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2196491. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.